ꯑꯅꯧꯕꯥ ꯔꯤꯁꯔꯆ ꯑꯃꯅꯥ ꯃꯥꯄꯂꯒꯤ ꯃꯇꯨꯡ ꯏꯟꯅꯥ . ꯕ꯭ꯂꯗ ꯑꯣꯛꯁꯤꯖꯦꯅꯒꯤ ꯆꯥꯡ ꯑꯁꯤ ꯀꯣꯚꯤꯗ-꯱꯹ ꯂꯩꯕꯥ ꯃꯤꯑꯣꯏꯁꯤꯡꯅꯥ ꯃꯈꯣꯌꯒꯤ ꯍꯀꯁꯦꯜ ꯐꯒꯠꯂꯀꯄꯥ ꯌꯥꯏ ꯍꯥꯌꯕꯒꯤ ꯈꯨꯗꯃꯁꯤꯡ ꯎꯕꯥ ꯐꯪꯕꯒꯤ ꯁꯥꯐꯕꯥ ꯃꯑꯣꯡ ꯑꯃꯅꯤ꯫ ꯌꯨꯃꯗꯥ ꯄꯂꯁ ꯑꯣꯛꯁꯤꯃꯤꯇꯔꯁꯤꯡ ꯑꯁꯤ ꯄꯥꯛ-ꯁꯟꯅꯥ ꯐꯪꯏ, ꯃꯈꯣꯌꯒꯤ ꯕ꯭ꯂꯗ ꯑꯣꯛꯁꯤꯖꯦꯟ ꯁꯦꯆꯨꯔꯦꯁꯟ ꯑꯗꯨ ꯌꯦꯡꯁꯤꯟꯅꯕꯥ ꯃꯤꯑꯣꯏ ꯑꯃꯒꯤ ꯈꯨꯠꯁꯥꯒꯤ ꯈꯨꯠꯊꯥꯡꯗꯥ ꯃꯉꯥꯜ ꯄꯤꯕꯥ ꯂꯦꯝꯅꯥ ꯄꯤꯕꯥ ꯗꯤꯚꯥꯏꯁꯁꯤꯡꯅꯤ꯫ ꯄ꯭ꯔꯃꯥꯅꯁꯤꯡꯅꯥ ꯎꯠꯂꯦ ꯃꯗꯨꯗꯤ ꯕ꯭ꯂꯗ ꯑꯣꯛꯁꯤꯖꯦꯅꯒꯤ ꯆꯥꯡ ꯍꯟꯊꯔꯀꯄꯥ ꯑꯁꯤ ꯀꯣꯚꯤꯗ-꯱꯹ ꯄꯦꯁꯦꯟꯇ ꯑꯃꯒꯤ ꯍꯀꯁꯦꯜ ꯐꯒꯠꯂꯛꯂꯤ ꯑꯃꯁꯨꯡ ꯃꯈꯣꯌꯅꯥ ꯍꯦꯟꯅꯥ ꯅꯛꯅꯥ ꯌꯦꯡꯁꯤꯅꯕꯥ ꯑꯃꯁꯨꯡ ꯈꯨꯗꯛꯀꯤ ꯑꯣꯏꯕꯥ ꯂꯥꯌꯦꯡ ꯃꯊꯧ ꯇꯥꯕꯥ ꯌꯥꯏ ꯍꯥꯌꯕꯒꯤ ꯃꯔꯨꯑꯣꯏꯕꯥ ꯏꯟꯗꯤꯀꯦꯇꯔ ꯑꯃꯅꯤ꯫
ꯂꯦꯟꯁꯦꯠ ꯗꯤꯖꯤꯇꯦꯜ ꯍꯦꯜꯊꯇꯥ ꯐꯣꯉꯕꯥ ꯔꯤꯁꯔꯆ ꯑꯁꯤꯅꯥ ꯂꯩꯕꯥꯛ ꯃꯉꯥꯒꯤ ꯃꯔꯛꯇꯥ ꯆꯥꯎꯔꯥꯛꯅꯥ ꯁꯔꯨꯛ ꯌꯥꯈꯤꯕꯥ ꯳,꯰꯰꯰ ꯌꯥꯑꯣꯕꯥ ꯁ꯭ꯇꯗꯤ ꯱꯳ ꯌꯦꯡꯁꯤꯅꯈꯤ, ꯃꯁꯤꯒꯤ ꯃꯅꯨꯡꯗꯥ ꯑꯌꯥꯝꯕꯗꯤ ꯑꯍꯥꯅꯕꯥ ꯂꯥꯏꯆꯠ ꯇꯝꯄꯥꯛ ꯃꯅꯨꯡꯗꯥ ꯄꯥꯡꯊꯣꯀꯈꯤ꯫
ꯁꯥꯏꯟꯇꯤꯁ꯭ꯇꯁꯤꯡꯅꯥ ꯃꯦꯗꯤꯀꯦꯂꯒꯤ ꯒꯥꯏꯗꯂꯥꯏꯅꯁꯤꯡꯒꯥ ꯂꯣꯌꯅꯅꯥ, ꯍꯣꯝ ꯄꯂꯁ ꯑꯣꯛꯁꯤꯃꯦꯠꯔꯤꯅꯥ ꯁꯦꯐꯇꯤ ꯅꯦꯠ ꯑꯃꯥ ꯑꯣꯏꯅꯥ ꯊꯕꯛ ꯇꯧꯕꯥ ꯌꯥꯏ, ꯃꯁꯤꯅꯥ ꯌꯨꯃꯗꯥ ꯑꯁꯣꯏ-ꯑꯉꯥꯝ ꯌꯥꯑꯣꯗꯅꯥ ꯂꯩꯕꯥ ꯌꯥꯕꯥ ꯑꯅꯥꯕꯁꯤꯡꯒꯤꯗꯃꯛꯇꯥ ꯃꯊꯧ ꯇꯥꯗꯕꯥ ꯏꯃꯔꯖꯦꯟꯁꯤ ꯑꯃꯁꯨꯡ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯂꯒꯤ ꯑꯦꯗꯃꯤꯁꯟ ꯍꯟꯊꯍꯅꯕꯥ ꯉꯃꯒꯅꯤ, ꯑꯗꯨꯒꯥ ꯃꯊꯧ ꯇꯥꯔꯤꯕꯥ ꯃꯤꯑꯣꯏꯁꯤꯡꯗꯥ ꯉꯟꯅꯥ ꯍꯟꯊꯔꯀꯄꯥ ꯑꯃꯁꯨꯡ ꯀꯦꯌꯔ ꯍꯦꯅꯒꯠꯂꯀꯄꯒꯤ ꯈꯨꯗꯃꯁꯤꯡ ꯎꯕꯥ ꯐꯪꯏ꯫ ꯃꯁꯤꯅꯥ ꯇꯞꯅꯥ ꯇꯞꯅꯥ ꯔꯤꯁꯣꯔꯁꯁꯤꯡ ꯁꯦꯚ ꯇꯧꯕꯗꯥ ꯃꯇꯦꯡ ꯄꯥꯡꯒꯅꯤ, ꯑꯃꯁꯨꯡ ꯍꯀꯁꯦꯂꯒꯤ ꯁꯦꯇꯤꯡꯁꯤꯡꯗꯥ ꯀꯟꯇꯦꯛꯇ ꯇꯧꯕꯗꯒꯤ ꯚꯥꯏꯔꯁ ꯑꯁꯤ ꯃꯈꯥ ꯇꯥꯅꯥ ꯁꯟꯗꯣꯀꯄꯥ ꯍꯟꯊꯍꯅꯒꯅꯤ꯫
ꯑꯗꯨꯝ ꯑꯣꯏꯅꯃꯛ, ꯊꯦꯔꯦꯁꯥꯔꯆꯔꯁꯤꯡꯅꯥ ꯍꯦꯟꯅꯥ ꯃꯌꯦꯛ ꯁꯦꯡꯕꯥ ꯈꯣꯡꯎꯄꯀꯤ ꯑꯅꯥꯕꯁꯤꯡꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯔꯤꯁꯔꯆ ꯇꯧꯕꯥ ꯉꯃꯗꯕꯥ ꯑꯁꯤ ꯅꯣꯠ ꯇꯧꯔꯤ, ꯃꯈꯣꯌꯒꯤꯗꯃꯛꯇꯥ ꯑꯣꯛꯁꯤꯃꯦꯠꯔꯤ ꯑꯁꯤ ꯁ꯭ꯕꯥꯌꯥꯃꯒꯤ ꯃꯤꯑꯣꯏꯁꯤꯡꯗꯒꯤ ꯍꯦꯟꯅꯥ ꯑꯆꯨꯝꯕꯥ ꯑꯣꯏꯕꯥ ꯌꯥꯏ꯫
ꯃꯈꯣꯌꯒꯤ ꯊꯤꯖꯤꯅꯕꯒꯤ ꯊꯕꯀꯁꯤꯡꯗꯥ ꯌꯨꯝꯐꯝ ꯑꯣꯏꯔꯒꯥ, ꯔꯤꯁꯔꯆꯔꯁꯤꯡꯅꯥ ꯍꯣꯝ ꯀꯣꯕꯤꯗ-꯱꯹ ꯃꯣꯅꯤꯇꯔ ꯇꯧꯕꯗꯥ ꯑꯣꯛꯁꯤꯃꯦꯠꯔꯤ ꯁꯤꯖꯤꯟꯅꯕꯒꯤ ꯁ꯭ꯇꯦꯟꯗꯔꯗ ꯑꯣꯏꯍꯅꯕꯗꯥ ꯃꯇꯦꯡ ꯄꯥꯡꯕꯥ ꯌꯥꯕꯥ ꯃꯔꯨꯑꯣꯏꯕꯥ ꯔꯤꯀꯃꯦꯟꯗꯦꯁꯅꯁꯤꯡꯒꯤ ꯁꯦꯠ ꯑꯃꯥ ꯃꯥꯡꯂꯣꯃꯗꯥ ꯄꯨꯈꯠꯈꯤ꯫
ꯃꯔꯨꯑꯣꯏꯅꯥ, ꯁ꯭ꯇꯗꯤ ꯑꯁꯤꯅꯥ ꯲꯰꯲꯰ꯗꯥ ꯂꯦꯄꯊꯣꯛꯂꯕꯥ ꯀꯠꯊꯣꯀꯄꯥ ꯄꯣꯏꯟꯇ ꯑꯃꯥ ꯁꯤꯖꯤꯟꯅꯅꯕꯥ ꯄꯥꯎꯇꯥꯛ ꯄꯤꯔꯤ꯫ ꯕ꯭ꯂꯗ ꯑꯣꯛꯁꯤꯖꯦꯅꯒꯤ ꯆꯥꯡ (꯹꯲%), ꯃꯁꯤꯅꯥ ꯍꯦꯜꯊꯀꯦꯌꯔ ꯄ꯭ꯔꯣꯐꯦꯁ꯭ꯅꯦꯂꯁꯤꯡꯅꯥ ꯑꯅꯥꯕꯥ ꯑꯃꯅꯥ ꯂꯥꯌꯦꯡꯅꯕꯥ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯂꯗꯥ ꯆꯠꯄꯥ ꯃꯇꯃꯗꯥ ꯀꯗꯥꯏꯗꯥ ꯆꯠꯄꯥ ꯃꯊꯧ ꯇꯥꯕꯒꯦ ꯍꯥꯌꯕꯗꯨ ꯂꯦꯄꯊꯣꯀꯄꯥ ꯉꯃꯍꯅꯒꯅꯤ, ꯅꯠꯠꯔꯒꯥ ꯃꯇꯝ ꯑꯗꯨꯗꯥ ꯃꯈꯣꯌꯅꯥ ꯃꯈꯥ ꯇꯥꯅꯥ ꯌꯦꯡꯁꯤꯅꯕꯒꯤ ꯃꯊꯧ ꯇꯥꯕꯥ ꯑꯗꯨ ꯂꯥꯀꯁꯤꯅꯕꯥ ꯉꯃꯒꯗ꯭ꯔꯥ ꯍꯥꯌꯕꯗꯨ ꯂꯦꯄꯊꯣꯀꯄꯥ ꯉꯃꯒꯅꯤ꯫
ꯏꯟꯁꯇꯤꯠꯌꯨꯠ ꯑꯣꯐ ꯒ꯭ꯂꯣꯕꯦꯜ ꯍꯦꯜꯊ ꯏꯅꯣꯕꯦꯁꯅꯒꯤ ꯔꯤꯁꯔꯆ ꯑꯦꯁꯣꯁꯤꯑꯦꯠ ꯗꯥꯛꯇꯔ ꯑꯍꯃꯦꯗ ꯑꯂꯕꯣꯛꯁꯃꯥꯇꯤꯅꯥ ꯍꯥꯌꯈꯤ: 'ꯄꯥꯀꯟꯇ ꯑꯁꯤ ꯂꯥꯏꯆꯠ ꯑꯁꯤꯒꯤ ꯃꯅꯨꯡꯗꯥ, ꯃꯤꯌꯥꯃꯒꯤ ꯃꯔꯛꯇꯥ ꯋꯥꯈꯜ ꯋꯥꯕꯥ ꯑꯁꯤ ‘ꯑꯩꯅꯥ ꯀꯣꯚꯤꯗ ꯇꯧꯈꯤꯕꯔꯥ?’ ꯍꯥꯌꯅꯥ ꯍꯣꯡꯗꯣꯀꯈ꯭ꯔꯦ꯫ ‘ꯀꯔꯤꯒꯨꯝꯕꯥ ꯑꯩꯅꯥ ꯀꯣꯚꯤꯗ ꯐꯪꯂꯕꯗꯤ ꯑꯩꯅꯥ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯂꯗꯥ ꯆꯠꯄꯥ ꯃꯊꯧ ꯇꯥꯕꯔꯥ?
'ꯄꯂꯁ ꯑꯣꯛꯁꯤꯃꯦꯠꯔꯤ ꯑꯁꯤ ꯃꯁꯥꯅꯥ ꯁꯤꯖꯤꯟꯅꯕꯗꯥ ꯂꯥꯌꯕꯥ, ꯃꯃꯂꯗꯥ ꯃꯃꯜ ꯍꯣꯡꯕꯥ, ꯄꯥꯛ ꯁꯟꯅꯥ ꯁꯤꯖꯤꯟꯅꯕꯥ ꯌꯥꯕꯥ, ꯑꯃꯁꯨꯡ ꯑꯩꯈꯣꯌꯅꯥ ꯎꯠꯂꯤꯕꯥ ꯑꯁꯤꯒꯨꯝꯅꯥ, ꯀꯣꯚꯤꯗ-꯱꯹ ꯄꯦꯁꯦꯟꯇꯁꯤꯡꯗꯥ ꯍꯀꯁꯦꯜ ꯐꯒꯠꯂꯀꯄꯥ ꯈꯉꯗꯣꯛꯅꯕꯥ ꯀꯥꯟꯅꯕꯥ ꯃꯑꯣꯡ ꯑꯃꯅꯤ꯫'
ꯁ꯭ꯃꯥꯔꯇꯐꯣꯟ ꯑꯃꯁꯨꯡ ꯃꯣꯕꯥꯏꯜ ꯑꯦꯞ ꯈꯔꯗꯁꯨ ꯕ꯭ꯂꯗ ꯑꯣꯛꯁꯤꯖꯦꯅꯒꯤ ꯆꯥꯡ ꯃꯥꯄꯂꯒꯤ ꯑꯣꯏꯕꯥ ꯉꯝꯕꯒꯤ ꯊꯧꯅꯥ ꯂꯩ, ꯃꯁꯤ ꯔꯤꯁꯔꯆꯔꯁꯤꯡꯅꯥ ꯃꯁꯛ ꯈꯉꯗꯣꯛꯂꯤ ꯃꯗꯨꯗꯤ ꯃꯁꯤꯅꯥ ꯄꯥꯛ ꯁꯟꯅꯥ ꯁꯤꯖꯤꯟꯅꯕꯥ ꯌꯥꯕꯥ ꯃꯣꯅꯤꯇꯔ ꯇꯧꯕꯒꯤ ꯈꯨꯠꯂꯥꯌ ꯑꯃꯅꯤ꯫ ꯑꯗꯨꯝ ꯑꯣꯏꯅꯃꯛ, ꯁ꯭ꯇꯗꯤ ꯈꯔꯅꯥ ꯇ꯭ꯔꯦꯗꯤꯁ꯭ꯅꯦꯜ ꯄꯂꯁ ꯑꯣꯛꯁꯤꯃꯤꯇꯔꯒꯥ ꯃꯥꯟꯅꯕꯥ ꯑꯆꯨꯝꯕꯥ ꯔꯤꯄꯣꯔꯠ ꯇꯧꯔꯀꯈꯤꯕꯥ ꯃꯇꯃꯗꯥ, ꯔꯤꯁꯔꯆꯔꯁꯤꯡꯅꯥ ꯃꯈꯣꯌꯒꯤ ꯀ꯭ꯂꯤꯅꯤꯀꯦꯜ ꯃꯣꯅꯤꯇꯔ ꯇꯧꯕꯗꯥ ꯁꯤꯖꯤꯟꯅꯅꯕꯥ ꯍꯧꯖꯤꯛ ꯐꯥꯑꯣꯕꯗꯥ ꯄ꯭ꯔꯃꯥꯟ ꯃꯔꯥꯡ ꯀꯥꯌꯅꯥ ꯂꯩꯇꯦ ꯍꯥꯌꯅꯥ ꯋꯥꯔꯦꯞ ꯂꯧꯈꯤ꯫
ꯁ꯭ꯇꯗꯤ ꯑꯁꯤꯅꯥ ꯍꯧꯖꯤꯛ ꯂꯩꯔꯤꯕꯥ ꯄ꯭ꯔꯃꯥꯅꯁꯤꯡ ꯑꯁꯤꯗꯥ ꯃꯈꯥ ꯇꯥꯕꯥ ꯒꯦꯄꯁꯤꯡꯁꯨ ꯈꯉꯗꯣꯀꯈꯤ, ꯃꯔꯨꯑꯣꯏꯅꯥ ꯄꯂꯁ ꯑꯣꯛꯁꯤꯃꯦꯠꯔꯤꯅꯥ ꯑꯅꯥꯕꯁꯤꯡꯒꯤ ꯍꯀꯁꯦꯂꯒꯤ ꯐꯤꯚꯝ ꯐꯒꯠꯍꯅꯕꯥ ꯉꯃꯒꯗ꯭ꯔꯥ ꯍꯥꯌꯕꯗꯨ ꯈꯉꯗꯣꯛꯅꯕꯥ ꯗꯦꯇꯥ ꯃꯔꯥꯡ ꯀꯥꯌꯅꯥ ꯂꯩꯇꯕꯥ꯫
Dr Ana Luisa Neves, Advanced Research Fellow from the Institute of Global Health Innovation, said: 'Our research has demonstrated how the use of pulse oximetry in remote patient monitoring could help ease the strains on health systems during the COVID-19 pandemic. However, it's vital to ensure that the current lack of research in racially and ethnically diverse populations is addressed. It's therefore critical to provide support to ensure this technology reduces, rather than entrenches, existing health ꯃꯥꯟꯅꯕꯥ ꯂꯩꯇꯕꯥ꯫
ꯑꯍꯦꯅꯕꯥ ꯏꯅꯐꯣꯔꯃꯦꯁꯅꯒꯤꯗꯃꯛꯇꯥ ꯆꯥꯅꯕꯤꯗꯨꯅꯥ ꯚꯤꯖꯤꯠ ꯇꯧꯕꯤꯌꯨ www.sejoygroup.com ꯗꯥ ꯊꯥꯕꯤꯔꯀꯎ꯫